Comparative risk of herpes zoster in patients with psoriatic disease on systemic treatments: a systematic review and network meta-analysis.

Hsien-Yi Chiu Yi-Teng HungShi-Wei HuangYu-Huei Huang

Published in: Therapeutic advances in chronic disease (2022)

The NMA demonstrated CS, infliximab, and JAKi (tofacitinib), and several combination treatments were associated with higher HZ risk in patients with psoriasis and psoriatic arthritis. Differences in HZ risk should be taken into consideration when considering optimal psoriasis treatment.

Keyphrases

rheumatoid arthritis
ulcerative colitis
ankylosing spondylitis
atopic dermatitis
drug induced